Fra2/FOSL2

Fra-2/FOSL2 is a Fos family AP-1 transcription factor subunit that forms heterodimers with JUN proteins and regulates gene-expression programs involved in cellular differentiation, proliferation, and tissue remodeling^[1]. Mechanistically, FOSL2 functions within the AP-1 signaling network and mediates selective genomic targeting of transcriptional responses, enabling context-dependent control of downstream genes across multiple cell types^[1]. Through this transcriptional activity, FOSL2 has emerged as a regulator of immune, fibrotic, and inflammatory processes, linking AP-1 signaling to pathological tissue remodeling^[2][3]. In disease models, transgenic overexpression of Fosl2 induces systemic immune dysregulation and T-cell-mediated inflammation, demonstrating a direct role in immune homeostasis and autoimmunity-related pathways^[2]. Consistent with these findings, Fosl2-overexpressing mice serve as experimental models of systemic sclerosis and develop pronounced fibrotic phenotypes, including myocardial fibrosis, conduction abnormalities, and cardiac arrhythmias associated with profibrotic transcriptional programs^[3]. Compared with the closely related AP-1 family member FOSL1 (Fra-1), FOSL2 exhibits distinct genomic interaction networks and transcriptional regulatory functions, supporting nonredundant roles within AP-1 complexes despite their structural similarity^[4]. For experimental applications, genetic overexpression and knockdown approaches are widely used to define FOSL2-dependent transcriptional circuits and to investigate mechanisms underlying fibrosis, immune dysfunction, and tissue remodeling^[1][2][3].